Literature DB >> 15741992

Frequency of large CFTR gene rearrangements in Italian CF patients.

Cristina Bombieri1, Alberto Bonizzato, Carlo Castellani, Baroukh M Assael, Pier Franco Pignatti.   

Abstract

In most populations, an appreciable fraction of cystic fibrosis transmembrane regulator (CFTR) gene mutations in patients affected by cystic fibrosis (CF) cannot be identified, and large gene rearrangements might be missed by standard analyses. We have searched large gene rearrangements in a sample of 25 North East Italian CF patients who, after an extensive gene analysis of 188 patients, still bear one or two unidentified CF mutations. A systematic gene screening by quantitative multiplex PCR of short fluorescent fragments was performed. Overall, 5/26 (19.2%) rearranged alleles were detected, bearing mutation 3120+1Kbdel8.6Kb (three patients), and c.4_IVS1+69del119bpins299bp (two patients). These mutations were observed in compound heterozygotes with F508del or termination mutations, and a pancreatic insufficient form of CF. These findings confirm the frequency of CFTR gene rearrangements recently observed in French CF patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741992     DOI: 10.1038/sj.ejhg.5201387

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  10 in total

1.  A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening.

Authors:  Valeria Faà; Pietro Pellegrini Bettoli; Maria Demurtas; Maurizio Zanda; Vincenzina Ferri; Antonio Cao; Maria Cristina Rosatelli
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

2.  Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders--updated European recommendations.

Authors:  Els Dequeker; Manfred Stuhrmann; Michael A Morris; Teresa Casals; Carlo Castellani; Mireille Claustres; Harry Cuppens; Marie des Georges; Claude Ferec; Milan Macek; Pier-Franco Pignatti; Hans Scheffer; Marianne Schwartz; Michal Witt; Martin Schwarz; Emmanuelle Girodon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

3.  PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1.

Authors:  Patricia Combes; Marie-Noelle Bonnet-Dupeyron; Fernande Gauthier-Barichard; Raphael Schiffmann; Enrico Bertini; Diana Rodriguez; John A L Armour; Odile Boespflug-Tanguy; Catherine Vaurs-Barrière
Journal:  Neurogenetics       Date:  2006-01-17       Impact factor: 2.660

4.  Extensive sequencing of the CFTR gene: lessons learned from the first 157 patient samples.

Authors:  Matthew J McGinniss; Christina Chen; Joy B Redman; Arlene Buller; Franklin Quan; Mei Peng; Robert Giusti; Feras M Hantash; Donghui Huang; Weimin Sun; Charles M Strom
Journal:  Hum Genet       Date:  2005-09-28       Impact factor: 4.132

5.  Homozygous Deletion of the CFTR Gene Caused by Interstitial Maternal Isodisomy in a Peruvian Child with Cystic Fibrosis.

Authors:  Flor Vásquez Sotomayor; Hugo Hernán Abarca-Barriga
Journal:  J Pediatr Genet       Date:  2019-02-13

6.  Identification of the second CFTR mutation in patients with congenital bilateral absence of vas deferens undergoing ART protocols.

Authors:  Rossella Giuliani; Ivana Antonucci; Isabella Torrente; Paola Grammatico; Giandomenico Palka; Liborio Stuppia
Journal:  Asian J Androl       Date:  2010-07-26       Impact factor: 3.285

7.  Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci.

Authors:  Sylvia Quemener; Jian-Min Chen; Nadia Chuzhanova; Caroline Bénech; Teresa Casals; Milan Macek; Thierry Bienvenu; Trudi McDevitt; Philip M Farrell; Ourida Loumi; Taieb Messaoud; Harry Cuppens; Garry R Cutting; Peter D Stenson; Karine Giteau; Marie-Pierre Audrézet; David N Cooper; Claude Férec
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

8.  Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders.

Authors:  Corinne Bareil; Caroline Guittard; Jean-Pierre Altieri; Carine Templin; Mireille Claustres; Marie des Georges
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

9.  Confirmation of single exon deletions in MLH1 and MSH2 using quantitative polymerase chain reaction.

Authors:  Cecily P Vaughn; Elaine Lyon; Wade S Samowitz
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

10.  Large genomic rearrangements in the CFTR gene contribute to CBAVD.

Authors:  Magali Taulan; Anne Girardet; Caroline Guittard; Jean-Pierre Altieri; Carine Templin; Christophe Beroud; Marie des Georges; Mireille Claustres
Journal:  BMC Med Genet       Date:  2007-04-20       Impact factor: 2.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.